A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2015.10.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Review of Clinical Trials of Cetuximab Combined With Radiotherapy for Non-Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Anti-Angiogenetic Therapies for Central Nervous System Metastases From Non-Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2016English

Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Non-Small Cell Lung Cancer Clinical Trials Requiring Biopsies With Biomarker-Specific Results for Enrollment Provide Unique Challenges

Cancer
Cancer ResearchOncology
2017English

Taxotere: Clinical Trials in Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

AB034. Muscular Metastasis From Non-Small Cell Lung Cancer: A Case Report

Annals of Translational Medicine
Medicine
2016English

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P3.cr-18 Central Nervous System Activity of Checkpoint Inihibitor in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy